Three-year study brings new hope over bowel disease

NDM researchers will begin investigating treatments for inflammatory bowel disease to guide future therapies. The university has teamed up with the pharmaceutical firm Eli Lilly and Company to begin the three-year project. Professor Fiona Powrie said: "This exciting collaboration will be very informative to define patients with inflammatory bowel disease that are difficult to treat with current medications but might benefit from medicines that target novel immune pathways."